MeVis Medical Solutions AG Reports Half-Year Results and Adjusts Fiscal Forecast

On May 21, 2026, Bremen-based MeVis Medical Solutions AG disclosed its financial outcomes for the first half of the 2025/2026 fiscal year, alongside an adjusted forecast for the remainder of the fiscal period. The company, known for its software in image-based medicine, reported revenues of €7,861 thousand, a decline from the previous year's €8,438 thousand. EBIT plummeted from €1,853 thousand to €160 thousand due to lower revenue and increased personnel costs following the consolidation of MeVis Breast Care GmbH & Co. KG.

The adjustment to the fiscal forecast anticipates a slight increase in revenue to between €16.5 million and €17.0 million, down from the prior expectation of €17.5 to €18.0 million. The decline is attributed to reduced demand in the mammography sector and delays in Germany's lung cancer screening implementation. The EBIT forecast is now between €0.5 million and €1.0 million, reflecting these pressures.